| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/SONC.2003.50056 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0093775403700839?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:S0093775403700839?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 12720142 |
| P2093 | author name string | Valentina Rossi | |
| Enrica Morra | |||
| Patrizia Bernuzzi | |||
| Clara Cesana | |||
| Elisabetta Tresoldi | |||
| Davide Filippini | |||
| Sara Miqueleiz | |||
| Giovanna D'avanzo | |||
| P2860 | cites work | Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors | Q28216060 |
| Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit | Q33340648 | ||
| Waldenström's macroglobulinemia: clinical features, complications, and management | Q33810053 | ||
| Waldenström's macroglobulinaemia: laboratory diagnosis and treatment. | Q34014941 | ||
| Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases | Q34459090 | ||
| The spectrum of IgM monoclonal gammopathy in 430 cases | Q39595650 | ||
| Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). | Q43648005 | ||
| Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognition. | Q53557852 | ||
| Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. | Q55035735 | ||
| Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases | Q72843393 | ||
| Waldenström's macroglobulinemia | Q73520445 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| P304 | page(s) | 231-235 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Seminars in Oncology | Q14330412 |
| P1476 | title | Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease | |
| Smouldering Waldenstrom's macroglobulinemia: Factors predicting evolution to symptomatic disease | |||
| P478 | volume | 30 |
| Q35553334 | Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity | cites work | P2860 |
Search more.